Natus Medical Incorporated announced the appointment of Ilan Daskal, current Chief Financial Officer & Executive Vice President of Bio-RAD Laboratories, to its board of directors and audit committee effective March 19, 2020. Kenneth Ludlum has advised the board that he will not stand for re-election at the 2020 Annual Meeting of Stockholders. Mr. Ludlum has served on the Natus board of directors and as Chairman of the Audit Committee since 2002.